GitLife Biotech has launched www.CellRepo.com, the version control system for synthetic biology, alongside a suite of DNA-based biosecurity tools. Our technologies enable reproducibility and proof of ownership, facilitating scale in synthetic biology. To tie the VCS to the engineered asset we must mark the genome of the biological asset itself. To do so we have developed DNA barcodes to an unprecedented level of sophistication: creating biosecurity tools with varying levels of confidentiality and indelibility. Our protocols cover 90% of the strains used in engineering biology and we are developing more all the time. See www.CellRepo.com for more information and to register. We are a Newcastle University spin out, co-founded with the venture builder Cambridge Future Tech Ltd. We maintain laboratories and offices in both Newcastle and Cambridge, UK.
Employees: 1-10
Founded date: 2023
Investors 1
| Date | Name | Website |
| 26.10.2023 | Startup Fu... | sfccapital... |
Mentions in press and media 2
| Date | Title | Description |
| 25.03.2025 | The Rise of Startups: A New Era of Innovation in Europe | In the heart of Europe, a revolution is brewing. Startups are no longer the underdogs. They are the main players. Events like the START Summit and Tech.eu Summit are shining a spotlight on these emerging powerhouses. The energy is palpable.... |
| 19.03.2025 | Startups Take Main Stage: Startups On Stage at the Tech.eu Summit London 2025 | Join the Tech.eu Summit London 2025 on March 25-26 at the Queen Elizabeth II Centre for a chance to connect with leaders, entrepreneurs, and investors. This year, startups will take the main stage, presenting their ideas between expert pane... |